Research and Markets (http://www.researchandmarkets.com/research/nws758/the_controlling) has announced the addition of the "The Controlling Cancer Summit 2016 (London, UK - 17th-19th May 2016)" conference to their offering.

The annual Controlling Cancer Summit in an international academic event with plenty of opportunity for networking and debate.

In an informal setting, this meeting will bring you up to date with current research and thinking regarding screening, prevention and treatment in this ever-growing field. Presenting at this event, we will have a variety of clinicians, academics and members of the pharmaceutical industry; we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.

Talks Include:

- New therapeutic approaches and repurposed drugs for targeting of glioma stem cells and treatment of glioblastoma

- Nucleosomics®- Revolutionising Cancer Diagnostics

- NQO1, GSTM1, and GSTT1 genetic polymorphisms and the risk of developing cancer among Filipinos

- Targeted delivery of potential therapeutics to glioblastoma

- The surface and shape of the breast cancer tumors and its relationship with lymph node metastases

- DNA damage repair and p53 gene in platinum-drug resistance

- DNA repair gene polymorphisms as risk factors and chemotherapy response predictors for lung adenocarcinoma in Serbia:

- Omics biomarkers and their implication in cancer control

- Targeting death receptors for cancer treatment

- Targeting non death domain-containing TNFR family members for cancer therapy: direct, carcinoma cell-specific death by CD40 signalling

- Non-Natural Nucleosides as Therapeutic Agents Against Glioblastoma

- Targeted nanomedicines in cancer therapy

- DNA methylation in epithelial-to-mesenchymal transition

- Therapeutic targeting of erbB3 receptor for cancer treatment

- Targeting the tumour microenvironment in anti-cancer therapy

- Adoptive T cell Therapy for Cancer

- Biomarker and targeting approaches

- Last generations of self-assembling nanovectors for drug and gene delivery in cancer therapy

- DNA methylation in early detection and risk prediction of women specific cancers.

- Precious metals for cancer treatment - a novel approach

- The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis

For more information visit http://www.researchandmarkets.com/research/nws758/the_controlling